Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD

Abstract Chronic obstructive pulmonary disease (COPD) treatment guidelines do not currently include recommendations for escalation directly from monotherapy to triple therapy. This 12-week, double-blind, double-dummy study randomized 800 symptomatic moderate-to-very-severe COPD patients receiving ti...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandeep Bansal, Martin Anderson, Antonio Anzueto, Nicola Brown, Chris Compton, Thomas C. Corbridge, David Erb, Catherine Harvey, Morrys C. Kaisermann, Mitchell Kaye, David A. Lipson, Neil Martin, Chang-Qing Zhu, Alberto Papi
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Diseases of the respiratory system
RC705-779
Online Access:https://doaj.org/article/dac6017c105b4a2b8e947907b8317115
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/dac6017c105b4a2b8e947907b8317115

Similar Items